COMMUNIQUÉS West-GlobeNewswire

Catalyst Biosciences to Present at the Annual BIO CEO & Investor Conference

05/02/2019 - 14:00

SOUTH SAN FRANCISCO, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc., (Nasdaq: CBIO) a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]

Caladrius Biosciences to Present at Upcoming February Conferences

05/02/2019 - 14:00

BASKING RIDGE, N.J., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company with multiple technology [...]

Entasis Therapeutics Receives Positive Feedback from FDA End-of-Phase 2 Meeting for ETX2514SUL; Signs Rapid Diagnostic Agreement with bioMérieux

05/02/2019 - 14:00

Entasis to incorporate BIOFIRE® FILMARRAY® System, a rapid molecular diagnostic platform, into ETX2514SUL Phase 3 clinical trial, on track to initiate in 1Q 2019 WALTHAM, Mass., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Entasis [...]

GBT Announces New Employment Inducement Grants

05/02/2019 - 14:00

SOUTH SAN FRANCISCO, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on February 1, 2019, the compensation committee of GBT’s board of directors granted [...]

Inspire Medical Systems, Inc. Announces Additional Positive Coverage Policies Issued by Five Blue Cross Blue Shield Healthcare Plans

05/02/2019 - 14:00

MINNEAPOLIS, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY

05/02/2019 - 14:00

Going Forward, We Will Be Silent Regarding Future Expectations for REMOXY AUSTIN, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a clinical-stage drug development company, today [...]

PCI Biotech: Invitation to fourth quarter and preliminary 2018 result presentation

05/02/2019 - 13:56

Oslo, Norway, 05 February 2019 - PCI Biotech invites to a presentation of the company's fourth quarter and preliminary 2018 report on Wednesday 13 February 2019 at Oslo Cancer Cluster Innovation Park. Time: Wednesday [...]

BioSig Appoints John Kowalski to Lead Commercialization of PURE EP

05/02/2019 - 13:52

Electrophysiology Industry Veteran to Lead Sales Strategy for the Company’s Novel Cardiac Signal Acquisition and Processing Technology Santa Monica, CA, Feb. 05, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( [...]

Arch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor Conference

05/02/2019 - 13:50

FRAMINGHAM, Mass., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]

MediPharm Labs Aligns Leadership and Organizational Structure For Future Prosperity of Company

05/02/2019 - 13:45

TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (the “Company” or “MediPharm Labs”) the leader in specialized, research-driven cannabis extraction, is pleased to announce the [...]

Intensity Therapeutics to Participate in Panel at 2019 BIO CEO & Investor Conference

05/02/2019 - 13:35

WESTPORT, Conn., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc. , a clinical-stage biotechnology company developing proprietary technology and products to kill tumors and increase immune cell recognition [...]

Moleculin Announces the FDA has Granted Orphan Drug Designation for its Brain Tumor Drug

05/02/2019 - 13:30

HOUSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]

Recent American Society of Breast Surgeons (ASBrS) Guidelines are Favorable to Next Generation Cryoablation Developer, IceCure Medical

05/02/2019 - 13:30

Plans to Increase Presence at Global Interventional Oncology (IO) Medical Conferences CAESAREA, Israel, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Following the American Society of Breast Surgeons (ASBrS) Guideline, which were [...]

OpGen Completes Clinical Trials for its Initial FDA 510(k) Submission

05/02/2019 - 13:30

GAITHERSBURG, Md., Feb. 05, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that it has completed the clinical trials needed to support its 510(k) submission for the detection of antimicrobial [...]

Cyclacel Pharmaceuticals to Present at the 2019 BIO CEO & Investor Conference

05/02/2019 - 13:00

BERKELEY HEIGHTS, N.J., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]

Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results and Host Conference Call on February 12

05/02/2019 - 13:00

REHOVOT, Israel, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for the fourth quarter and [...]

Emerald Health Therapeutics Secures Proprietary Extraction Technology and Extraction Capabilities in Agreement with Indena

05/02/2019 - 13:00

Emerald receives certain exclusive rights to established Phytosome ® technology to enhance absorption and bioavailability of cannabinoid products Leading global extraction researcher and manufacturer to provide license [...]

Microbix Provides Quality Assessment Products Update

05/02/2019 - 13:00

New Customers, More Products, and Expanding Capacity TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, provides an update on [...]

BioCryst to Present ZENITH-1 Results at American Academy of Allergy, Asthma & Immunology Annual Meeting

05/02/2019 - 13:00

RESEARCH TRIANGLE PARK, N.C., Feb. 05, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present an abstract including results from the ZENITH-1 study at the [...]